-+ 0.00%
-+ 0.00%
-+ 0.00%

ATEA PHARMACEUTICALS - C-FORWARD PHASE 3 TRIAL TO REPORT TOPLINE RESULTS IN EARLY 2027

Reuters·07/28/2026 11:00:02

Please log in to view news